Mayzent for active secondary progressive Multiple Sclerosis MS

Mayzent is taken orally. It has been shown to slow the progression of disability progression in MS in people who are starting down the road of secondary progressive MS. This article gives the information. I still think that Ocrevus might be best although I know of no direct comparisons. I would like to see comparative studies or meta reviews of the efficacy of Ocrevus compared to Mayzent and other MS drugs. See

Mayzent ‘Will Change Lives’ of MS Patients Transitioning to SPMS, Novartis Says